Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
143 Ergebnisse
| GG0AXD | Halozyme Therapeutics Inc./Faktor/Long [5]/GOLDS | - | - | call | Halozyme Therapeutics Inc. | 56,448 | 75,990 | 4,901 | 6,000 % | - | Goldman Sachs | ||
| GG3JNZ | Halozyme Therapeutics Inc./Faktor/Short [2]/GOLDS | - | - | put | Halozyme Therapeutics Inc. | 105,840 | 92,966 | 1,964 | 15,000 % | - | Goldman Sachs | ||
| GU1UTX | Halozyme Therapeutics Inc./Faktor/Short [5]/GOLDS | - | - | put | Halozyme Therapeutics Inc. | 84,672 | 85,690 | 4,696 | 6,000 % | - | Goldman Sachs | ||
| GV6A5R | Halozyme Therapeutics Inc./Faktor/Long [10]/GOLDS | - | - | call | Halozyme Therapeutics Inc. | 63,504 | 78,415 | 10,105 | 3,000 % | - | Goldman Sachs | ||
| GV9XXN | Halozyme Therapeutics Inc./Faktor/Long [4]/GOLDS | - | - | call | Halozyme Therapeutics Inc. | 60,630 | 74,777 | 3,952 | 7,500 % | - | Goldman Sachs | ||
| GW00B9 | Halozyme Therapeutics Inc./Faktor/Long [3]/GOLDS | - | - | call | Halozyme Therapeutics Inc. | 53,893 | 72,756 | 2,973 | 10,000 % | - | Goldman Sachs | ||
| GW0XSX | Halozyme Therapeutics Inc./Faktor/Short [10]/GOLDS | - | - | put | Halozyme Therapeutics Inc. | 85,602 | 80,155 | 8,793 | -0,848 % | - | Goldman Sachs | ||
| GW1GF2 | Halozyme Therapeutics Inc./Faktor/Short [4]/GOLDS | - | - | put | Halozyme Therapeutics Inc. | 101,050 | 86,903 | - | 7,500 % | - | Goldman Sachs | ||
| GW1GGW | Halozyme Therapeutics Inc./Faktor/Short [3]/GOLDS | - | - | put | Halozyme Therapeutics Inc. | 107,787 | 88,924 | - | 10,000 % | - | Goldman Sachs | ||
| GW5XCE | Halozyme Therapeutics Inc./Faktor/Long [15]/GOLDS | - | - | call | Halozyme Therapeutics Inc. | 75,451 | 79,223 | - | 2,000 % | - | Goldman Sachs | ||
| GW6Q4T | Halozyme Therapeutics Inc./Faktor/Short [15]/GOLDS | - | - | put | Halozyme Therapeutics Inc. | 83,008 | 79,376 | - | -1,810 % | - | Goldman Sachs | ||
| GX4LN4 | Halozyme Therapeutics Inc./Faktor/Long [2]/GOLDS | - | - | call | Halozyme Therapeutics Inc. | 35,280 | 68,714 | 1,975 | 15,000 % | - | Goldman Sachs | ||
| JE0A5Y | Halozyme Therapeutics Inc./Faktor/Long [13]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 74,641 | 77,030 | - | 4,713 % | - | JP Morgan | ||
| JE0DLW | Halozyme Therapeutics Inc./Faktor/Long [15]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 75,470 | 77,490 | - | 4,144 % | - | JP Morgan | ||
| JE14PE | Halozyme Therapeutics Inc./Faktor/Long [13]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 74,641 | 77,030 | - | 4,713 % | - | JP Morgan | ||
| JE5357 | Halozyme Therapeutics Inc./Faktor/Long [10]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 63,440 | 63,440 | - | 21,524 % | - | JP Morgan | ||
| JE5359 | Halozyme Therapeutics Inc./Faktor/Long [12]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 63,910 | 63,910 | - | 20,943 % | - | JP Morgan | ||
| JE535B | Halozyme Therapeutics Inc./Faktor/Long [15]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 64,330 | 64,330 | - | 20,423 % | - | JP Morgan | ||
| JE535D | Halozyme Therapeutics Inc./Faktor/Short [8]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 70,800 | 70,800 | - | -12,420 % | - | JP Morgan | ||
| JE535E | Halozyme Therapeutics Inc./Faktor/Short [14]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 69,840 | 69,840 | - | -13,607 % | - | JP Morgan | ||
| JE535F | Halozyme Therapeutics Inc./Faktor/Short [12]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 69,920 | 69,920 | - | -13,508 % | - | JP Morgan | ||
| JE535G | Halozyme Therapeutics Inc./Faktor/Long [14]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 64,140 | 64,140 | - | 20,658 % | - | JP Morgan | ||
| JE57LD | Halozyme Therapeutics Inc./Faktor/Short [7]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 71,240 | 71,240 | - | -11,875 % | - | JP Morgan | ||
| JE57LE | Halozyme Therapeutics Inc./Faktor/Long [13]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 63,950 | 63,950 | - | 20,893 % | - | JP Morgan | ||
| JE57LF | Halozyme Therapeutics Inc./Faktor/Short [15]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 69,690 | 69,690 | - | -13,793 % | - | JP Morgan | ||
| JE57LG | Halozyme Therapeutics Inc./Faktor/Short [10]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 70,150 | 70,150 | - | -13,224 % | - | JP Morgan | ||
| JE57LH | Halozyme Therapeutics Inc./Faktor/Short [9]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 70,440 | 70,440 | - | -12,865 % | - | JP Morgan | ||
| JE57LR | Halozyme Therapeutics Inc./Faktor/Short [11]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 70,120 | 70,120 | - | -13,261 % | - | JP Morgan | ||
| JE57LT | Halozyme Therapeutics Inc./Faktor/Short [13]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 69,980 | 69,980 | - | -13,434 % | - | JP Morgan | ||
| JE7931 | Halozyme Therapeutics Inc./Faktor/Short [10]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 88,920 | 84,470 | - | 4,490 % | - | JP Morgan | ||
| JE7932 | Halozyme Therapeutics Inc./Faktor/Short [11]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 88,185 | 84,440 | - | 4,453 % | - | JP Morgan | ||
| JE7933 | Halozyme Therapeutics Inc./Faktor/Short [14]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 86,610 | 84,100 | - | 4,033 % | - | JP Morgan | ||
| JE7934 | Halozyme Therapeutics Inc./Faktor/Short [12]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 87,572 | 84,200 | - | 4,156 % | - | JP Morgan | ||
| JE9GD5 | Halozyme Therapeutics Inc./KO/Call [endlos]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 65,097 | 65,097 | 4,239 | 19,474 % | - | JP Morgan | ||
| JE9QUP | Halozyme Therapeutics Inc./KO/Call [endlos]/JPMD | - | - | call | Halozyme Therapeutics Inc. | 59,180 | 65,100 | 3,348 | 19,471 % | - | JP Morgan | ||
| JE9SGB | Halozyme Therapeutics Inc./Faktor/Short [15]/JPMD | - | - | put | Halozyme Therapeutics Inc. | 86,225 | 83,920 | - | 3,810 % | - | JP Morgan | ||
| JF00PZ | Halozyme Therapeutics Inc./KO/Put [endlos]/JPM | - | - | put | Halozyme Therapeutics Inc. | 88,626 | 88,626 | 5,791 | 9,632 % | - | JP Morgan | ||
| JF7KJJ | Halozyme Therapeutics Inc./KO/Call [endlos]/JPM | - | - | call | Halozyme Therapeutics Inc. | 34,039 | 34,039 | 1,620 | 57,894 % | - | JP Morgan | ||
| JH2LDP | Halozyme Therapeutics Inc./Faktor/Long [5]/JPM | - | - | call | Halozyme Therapeutics Inc. | 64,690 | 71,160 | 4,291 | 11,974 % | - | JP Morgan | ||
| JH2LDQ | Halozyme Therapeutics Inc./Faktor/Long [6]/JPM | - | - | call | Halozyme Therapeutics Inc. | 67,385 | 73,000 | 5,057 | 9,698 % | - | JP Morgan | ||
| JH2LDS | Halozyme Therapeutics Inc./Faktor/Long [7]/JPM | - | - | call | Halozyme Therapeutics Inc. | 69,310 | 74,260 | 5,894 | 8,140 % | - | JP Morgan | ||
| JH3GVC | Halozyme Therapeutics Inc./Faktor/Long [9]/JPM | - | - | call | Halozyme Therapeutics Inc. | 71,877 | 75,880 | 7,176 | 6,136 % | - | JP Morgan | ||
| JH3GVD | Halozyme Therapeutics Inc./Faktor/Long [10]/JPM | - | - | call | Halozyme Therapeutics Inc. | 72,775 | 76,420 | 7,682 | 5,468 % | - | JP Morgan | ||
| JH3GVG | Halozyme Therapeutics Inc./Faktor/Long [8]/JPM | - | - | call | Halozyme Therapeutics Inc. | 70,754 | 75,180 | 6,111 | 7,001 % | - | JP Morgan | ||
| JK5PAN | Halozyme Therapeutics Inc./Faktor/Long [3]/JPM | - | - | call | Halozyme Therapeutics Inc. | 53,908 | 62,860 | 2,773 | 22,241 % | - | JP Morgan | ||
| JK5PAS | Halozyme Therapeutics Inc./Faktor/Short [2]/JPM | - | - | put | Halozyme Therapeutics Inc. | 121,258 | 90,940 | 1,848 | 12,494 % | - | JP Morgan | ||
| JK5PB1 | Halozyme Therapeutics Inc./Faktor/Long [2]/JPM | - | - | call | Halozyme Therapeutics Inc. | 40,432 | 50,540 | 1,873 | 37,481 % | - | JP Morgan | ||
| JK5PB2 | Halozyme Therapeutics Inc./Faktor/Long [4]/JPM | - | - | call | Halozyme Therapeutics Inc. | 60,646 | 68,230 | 3,636 | 15,599 % | - | JP Morgan | ||
| JK5PB6 | Halozyme Therapeutics Inc./Faktor/Short [3]/JPM | - | - | put | Halozyme Therapeutics Inc. | 107,784 | 89,890 | 2,739 | 11,195 % | - | JP Morgan | ||
| JT5PAA | Halozyme Therapeutics Inc./Faktor/Long [2]/JPM | - | - | call | Halozyme Therapeutics Inc. | 40,432 | 50,540 | 1,883 | 37,481 % | - | JP Morgan |